Today's post is about NMDA receptor antibody encephalitis again and the prevalence of catatonia in this diagnosis:

Catatonia in Nmethyl-d-aspartate Receptor Antibody Encephalitis: Phenomenological Characteristics From a Systematic Review of Case Reports

Jordi Serra-Mestres 1, Beatriz Villagrasa-Blasco 2, Vikram Thacker 3, Walter Jaimes-Albornoz 4, Puja Sharma 3, Marco Isetta 5
    Gen Hosp Psychiatry 
[Online ahead of print]

    The url for the pdf is:

https://drive.google.com/file/d/1qxfVbBuHYFT7LzJuGNX9Kq0JcaHDOwMW/view?usp=sharing

  In this literature review, these authors found that catatonic symptoms were present in 60% of cases.
Please see the blog post of 2/8 for some discussion of the role of ECT in this diagnosis.

Comments

  1. Max FinkFebruary 23, 2020 at 8:48 AM

    NMDAR encephalitis, a newly identified systemic illness, is verified by a serum or CSF test developed in 2007. As 60% of the patients meet criteria for catatonia, each suggested patient should be examined for catatonia and considered for ECT.

    This lately defined illness is within the spectrum of catatonia, among the benign stupors, malignant catatonia, delirious manias and self injurious autistic adolescents who respond well to ECT. It should be added to the indications for ECT, to the conventional acceptance as treatment for severe mood disorders and schizophrenia.

    Recognizing these forms of catatonia as responsive to ECT is an unheralded achievement in recent medicine

    ReplyDelete

Post a Comment

Popular posts from this blog

ECT vs Ketamine: NEJM Article Sets Up False Equivalency

Image
Out on PubMed, from investigators in the US, is this study: Ketamine versus  ECT   for Nonpsychotic Treatment-Resistant Major Depression. Anand A, Mathew SJ, Sanacora G, Murrough JW, Goes FS, Altinay M, Aloysi AS, Asghar-Ali AA, Barnett BS, Chang LC, Collins KA, Costi S, Iqbal S, Jha MK, Krishnan K, Malone DA, Nikayin S, Nissen SE, Ostroff RB, Reti IM, Wilkinson ST, Wolski K, Hu B. N Engl J Med. 2023 May 24. doi: 10.1056/NEJMoa2302399. Online ahead of print. PMID:  37224232 The abstract is copied below: Background:  Electroconvulsive therapy (ECT) and subanesthetic intravenous ketamine are both currently used for treatment-resistant major depression, but the comparative effectiveness of the two treatments remains uncertain. Methods:  We conducted an open-label, randomized, noninferiority trial involving patients referred to ECT clinics for treatment-resistant major depression . Patients with treatment-resistant major depression without psychosis were recruited and assigned in a 1:1 rat
Read more

RUL ECT vs Low Amplitude Seizure Therapy (LAP-ST)

Image
Out on PubMed, from the team in Augusta, Georgia, is this study: Double-Blinded Randomized Pilot Clinical Trial Comparing Cognitive Side Effects of Standard Ultra-Brief Right Unilateral ECT to 0.5 A Low Amplitude Seizure Therapy (LAP-ST). Youssef NA, McCall WV, Ravilla D, McCloud L, Rosenquist PB. Brain Sci. 2020 Dec 13;10(12):E979. doi: 10.3390/brainsci10120979. PMID:  33322138 The pdf is here . And from the Introduction : In theory, LAP-ST can be helpful because of the direct effect of lower electric current, but the principal reason is that LAP-ST has a more focal electric field (EF) [ 34 , 35 ]. The current amplitude is the primary factor that drives the EF into brain regions located deeper in the brain and is responsible for cognition and memory such as the hippocampus and temporal lobe [ 33 , 35 ]. This extra focality of the EF can minimize or avoid high EF stimulation to the deeper hippocampal and temporal lobe regions [ 33 , 35 ]. Minimization of deeper stimulation by using LAP
Read more

ECT For Children at a University Hospital: New Study in JECT

Image
 Out on PubMed, from authors at Vanderbilt and Mass General,, is this article: Use of   ECT   for Children With and Without Catatonia: A Single-Site Retrospective Analysis. Smith JR, Baldwin I, Termini KA, McGonigle T, Vandekar S, Luccarelli J. J ECT. 2024 Jan 25. doi: 10.1097/YCT.0000000000000993. Online ahead of print. PMID:  38265759 The abstract is copied below: Objectives: The objective study was to investigate the safety and efficacy of electroconvulsive therapy (ECT) in a retrospective cohort of pediatric patients. Methods: A single-site retrospective analysis was conducted of patients aged younger than 18 years who received ECT in a private university hospital from January 28, 2012 to April 8, 2023. Treatment efficacy and adverse events were determined retrospectively through review of the medical record. Results: A total of 36 pediatric patients met the inclusion criteria. Catatonia was the most common presenting indication for ECT, followed by psychosis and suicidal ideation.
Read more